Finch Therapeutics Group, Inc.
FNCHDelisted Oct 31, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001733257
Finch Therapeutics Group, Inc. was delisted on Oct 31, 2024; its insiders filed their last Form 4 on Jun 10, 2024; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Finch Therapeutics Group, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 40 | 33 | −7 |
| Shares | 9.59M | 9.55M | −38.5K (−0.4%) |
| Value | $4.60M | $3.75M | −$848.4K (−18.4%) |
New holders (0)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
None.
Sold out (7)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| TRB Advisors LP | 570,000 | $274.0K |
| Oasis Management Co Ltd. | 225,000 | $108.0K |
| Bridgeway Capital Management, LLC | 164,267 | $78.8K |
| Goldman Sachs Group Inc | 17,135 | $8.22K |
| FMR LLC | 1,000 | $480 |
| Northwestern Mutual Wealth Management Co | 600 | $288 |
| Barclays PLC | 106 | $51 |